Colorectal Cancer Screening Market Size, Share & Industry Analysis, By Type (Stool-based (Fecal Immunochemical Test (FIT), Fecal Occult Blood Test (FOBT), and Stool-DNA Test), Colonoscopy, and Others), By End-user (Hospitals & Clinics, Clinical Laboratories, Diagnostics Imaging Centers, and Others), and Regional Forecast, 2026-2034

Last Updated: January 13, 2026 | Format: PDF | Report ID: FBI101144

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Incidence of Colorectal Cancer (2020) - For Key Countries, 2025
2. Overview : Colorectal Cancer Screening Programs (Key Countries/ Regions)
3. New Product Approvals
4. Overview: Public Private Partnerships, Strategies Implemented by Organizations for Colorectal Cancer Screening - Key Countries
5. Number of Colorectal Cancer Screening Procedures - For Key Countries, 2025
6. Average Prices of the Tests in the Market
7. Key Industry Developments (Mergers, Acquisitions, Partnerships)
8. Overview : Countries with Overburden of Colonoscopies
Global Colorectal Cancer Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Stool-based
    1. Fecal Immunochemical Test (FIT)
    2. Fecal Occult Blood Test (FOBT)
    3. Stool-DNA Test
  2. Colonoscopy
  3. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Diagnostic Imaging Centers
  4. Others
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Colorectal Cancer Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Stool-based
    1. Fecal Immunochemical Test (FIT)
    2. Fecal Occult Blood Test (FOBT)
    3. Stool-DNA Test
  2. Colonoscopy
  3. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Diagnostic Imaging Centers
  4. Others
3. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Colorectal Cancer Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Stool-based
    1. Fecal Immunochemical Test (FIT)
    2. Fecal Occult Blood Test (FOBT)
    3. Stool-DNA Test
  2. Colonoscopy
  3. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Diagnostic Imaging Centers
  4. Others
3. Market Analysis – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia pacific Colorectal Cancer Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Stool-based
    1. Fecal Immunochemical Test (FIT)
    2. Fecal Occult Blood Test (FOBT)
    3. Stool-DNA Test
  2. Colonoscopy
  3. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Diagnostic Imaging Centers
  4. Others
3. Market Analysis – By Country/Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Colorectal Cancer Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Stool-based
    1. Fecal Immunochemical Test (FIT)
    2. Fecal Occult Blood Test (FOBT)
    3. Stool-DNA Test
  2. Colonoscopy
  3. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Diagnostic Imaging Centers
  4. Others
3. Market Analysis – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Colorectal Cancer Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Stool-based
    1. Fecal Immunochemical Test (FIT)
    2. Fecal Occult Blood Test (FOBT)
    3. Stool-DNA Test
  2. Colonoscopy
  3. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Diagnostic Imaging Centers
  4. Others
3. Market Analysis – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Company Share Analysis for Stool-based Tests, 2025
2. Company Share Analysis for Colonoscopes, 2025
3. Company Profiles ((Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. NOVIGENIX SA
  2. EIKEN CHEMICAL CO., LTD.
  3. Clinical Genomics Technologies Pty Ltd.
  4. Exact Sciences Corporation
  5. Epigenomics AG
  6. bioMérieux, Inc.
  7. OLYMPUS CORPORATION
  8. KARL STORZ SE & Co. KG
  9. FUJIFILM Holdings America Corporation

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Incidence of Colorectal Cancer (2020) - For Key Countries, 2025
2. Overview : Colorectal Cancer Screening Programs (Key Countries/ Regions)
3. New Product Approvals
4. Overview: Public Private Partnerships, Strategies Implemented by Organizations for Colorectal Cancer Screening - Key Countries
5. Number of Colorectal Cancer Screening Procedures - For Key Countries, 2025
6. Average Prices of the Tests in the Market
7. Key Industry Developments (Mergers, Acquisitions, Partnerships)
8. Overview : Countries with Overburden of Colonoscopies
Global Colorectal Cancer Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Stool-based
    1. Fecal Immunochemical Test (FIT)
    2. Fecal Occult Blood Test (FOBT)
    3. Stool-DNA Test
  2. Colonoscopy
  3. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Diagnostic Imaging Centers
  4. Others
3. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Colorectal Cancer Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Stool-based
    1. Fecal Immunochemical Test (FIT)
    2. Fecal Occult Blood Test (FOBT)
    3. Stool-DNA Test
  2. Colonoscopy
  3. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Diagnostic Imaging Centers
  4. Others
3. Market Analysis – By Country
  1. U.S.
  2. Canada
Europe Colorectal Cancer Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Stool-based
    1. Fecal Immunochemical Test (FIT)
    2. Fecal Occult Blood Test (FOBT)
    3. Stool-DNA Test
  2. Colonoscopy
  3. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Diagnostic Imaging Centers
  4. Others
3. Market Analysis – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia pacific Colorectal Cancer Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Stool-based
    1. Fecal Immunochemical Test (FIT)
    2. Fecal Occult Blood Test (FOBT)
    3. Stool-DNA Test
  2. Colonoscopy
  3. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Diagnostic Imaging Centers
  4. Others
3. Market Analysis – By Country/Sub-region
  1. China
  2. India
  3. Japan
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Colorectal Cancer Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Stool-based
    1. Fecal Immunochemical Test (FIT)
    2. Fecal Occult Blood Test (FOBT)
    3. Stool-DNA Test
  2. Colonoscopy
  3. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Diagnostic Imaging Centers
  4. Others
3. Market Analysis – By Country/Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Colorectal Cancer Screening Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast – By Type
  1. Stool-based
    1. Fecal Immunochemical Test (FIT)
    2. Fecal Occult Blood Test (FOBT)
    3. Stool-DNA Test
  2. Colonoscopy
  3. Others
2. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Diagnostic Imaging Centers
  4. Others
3. Market Analysis – By Country/Sub-region
  1. GCC
  2. South Africa
  3. Rest of Middle East & Africa
Competitive Analysis
1. Company Share Analysis for Stool-based Tests, 2025
2. Company Share Analysis for Colonoscopes, 2025
3. Company Profiles ((Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. NOVIGENIX SA
  2. EIKEN CHEMICAL CO., LTD.
  3. Clinical Genomics Technologies Pty Ltd.
  4. Exact Sciences Corporation
  5. Epigenomics AG
  6. bioMérieux, Inc.
  7. OLYMPUS CORPORATION
  8. KARL STORZ SE & Co. KG
  9. FUJIFILM Holdings America Corporation

Read Less

List of Figures

Figure 01: Global Colorectal Cancer Screening Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 02: Global Colorectal Cancer Screening Market Value Share (%), By Test Type, 2025 & 2034

Figure 03: Global Colorectal Cancer Screening Market Value Share (%), By End-user, 2025 & 2034

Figure 04: Global CRO Market Value Share (%), By Region, 2025 & 2034

Figure 05: North America Colorectal Cancer Screening Market Value (USD billion), by Test Type, 2025 & 2034

Figure 06: North America Colorectal Cancer Screening Market Value Share (%), by Test Type, 2025

Figure 07: North America Colorectal Cancer Screening Market Value (USD billion), by End-user, 2025 & 2034

Figure 08: North America Colorectal Cancer Screening Market Value Share (%), by End-user, 2025

Figure 09: North America Colorectal Cancer Screening Market Value (USD billion), by Country, 2025 & 2034

Figure 10: North America Colorectal Cancer Screening Market Value Share (%), by Country, 2025

Figure 11: Europe Colorectal Cancer Screening Market Value (USD billion), by Test Type, 2025 & 2034

Figure 12: Europe Colorectal Cancer Screening Market Value Share (%), by Test Type, 2025

Figure 13: Europe Colorectal Cancer Screening Market Value (USD billion), by End-user, 2025 & 2034

Figure 14: Europe Colorectal Cancer Screening Market Value Share (%), by End-user, 2025

Figure 15: Europe Colorectal Cancer Screening Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 16: Europe Colorectal Cancer Screening Market Value Share (%), by Country/Sub-region, 2025

Figure 17: Asia Pacific Colorectal Cancer Screening Market Value (USD billion), by Test Type, 2025 & 2034

Figure 18: Asia Pacific Colorectal Cancer Screening Market Value Share (%), by Test Type, 2025

Figure 19: Asia Pacific Colorectal Cancer Screening Market Value (USD billion), by End-user, 2025 & 2034

Figure 20: Asia Pacific Colorectal Cancer Screening Market Value Share (%), by End-user, 2025

Figure 21: Asia Pacific Colorectal Cancer Screening Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 22: Asia Pacific Colorectal Cancer Screening Market Value Share (%), by Country/Sub-region, 2025

Figure 23: Latin America Colorectal Cancer Screening Market Value (USD billion), by Test Type, 2025 & 2034

Figure 24: Latin America Colorectal Cancer Screening Market Value Share (%), by Test Type, 2021

Figure 25: Latin America Colorectal Cancer Screening Market Value (USD billion), by End-user, 2025 & 2034

Figure 26: Latin America Colorectal Cancer Screening Market Value Share (%), by End-user, 2025

Figure 27: Latin America Colorectal Cancer Screening Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 28: Latin America Colorectal Cancer Screening Market Value Share (%), by Country/Sub-region, 2025

Figure 29: Middle East & Africa Colorectal Cancer Screening Market Value Share (%), by Test Type, 2025

Figure 30: Middle East & Africa Colorectal Cancer Screening Market Value (USD billion), by Test Type, 2025 & 2034

Figure 31: Middle East & Africa Colorectal Cancer Screening Market Value (USD billion), by End-user, 2025 & 2034

Figure 32: Middle East & Africa Colorectal Cancer Screening Market Value Share (%), by End-user, 2025

Figure 33: Middle East & Africa Colorectal Cancer Screening Market Value (USD billion), by Country/Sub-region, 2025 & 2034

Figure 34: Middle East & Africa Colorectal Cancer Screening Market Value Share (%), by Country/Sub-region, 2025

Figure 35: Global Market Share Analysis for Stool-based Tests, By Company, 2025

Figure 36: Global Market Share Analysis for Colonoscopes, By Company, 2025

List of Tables

Table 01: Global Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Test Type, 2021-2034

Table 02: Global Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Stool-based, 2021-2034

Table 03: Global Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By End-user, 2021-2034

Table 04: Global Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Region, 2021-2034

Table 05: North America Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Test Type, 2021-2034

Table 06: North America Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Stool-based, 2021-2034

Table 07: North America Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By End-user, 2021-2034

Table 08: North America Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 09: Europe Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Test Type, 2021-2034

Table 10: Europe Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Stool-based, 2021-2034

Table 11: Europe Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By End-user, 2021-2034

Table 12: Europe Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034

Table 13: Asia Pacific Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Test Type, 2021-2034

Table 14: Asia Pacific Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Stool-based, 2021-2034

Table 15: Asia Pacific Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By End-user, 2021-2034

Table 16: Asia Pacific Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034

Table 17: Latin America Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Test Type, 2021-2034

Table 18: Latin America Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Stool-based, 2021-2034

Table 19: Latin America Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By End-user, 2021-2034

Table 20: Latin America Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034

Table 21: Middle East & Africa Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Test Type, 2021-2034

Table 22: Middle East & Africa Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Stool-based, 2021-2034

Table 23: Middle East & Africa Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By End-user, 2021-2034

Table 24: Middle East & Africa Colorectal Cancer Screening Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 140

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com